| 4 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
| 1.6M |
| $585.3M |
| +8.1% |
| 5.342% |
| 0.03% |
| 5 | STATE STREET CORP | 1.4M | $502.2M | +2.8% | 4.583% | 0.01% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $461.1M | +6.5% | 4.208% | 0.01% |
| 7 | Soleus Capital Management, L.P. | 939K | $349.1M | -18.5% | 3.186% | 12.03% |
| 8 | Capital World Investors | 778K | $289.1M | -5.7% | 2.639% | 0.03% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 699K | $259.8M | +8.5% | 2.371% | 0.01% |
| 10 | Hood River Capital Management LLC | 663K | $246.6M | +7.1% | 2.250% | 1.79% |
| 11 | Redmile Group, LLC | 632K | $234.9M | -6.2% | 2.144% | 15.77% |
| 12 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 570K | $211.9M | +40.0% | 1.934% | 0.64% |
| 13 | Frazier Life Sciences Management, L.P. | 481K | $178.9M | 0.0% | 1.633% | 3.90% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 476K | $176.9M | +1.5% | 1.615% | 0.03% |
| 15 | FIRST TRUST ADVISORS LP | 325K | $120.8M | -7.3% | 1.102% | 0.07% |
| 16 | Invesco Ltd. | 325K | $120.7M | +29.2% | 1.102% | 0.01% |
| 17 | GOLDMAN SACHS GROUP INC | 299K | $111.1M | +39.0% | 1.014% | 0.01% |
| 18 | NORTHERN TRUST CORP | 284K | $105.5M | +12.4% | 0.963% | 0.01% |
| 19 | FRANKLIN RESOURCES INC | 262K | $97.3M | +46.1% | 0.889% | 0.02% |
| 20 | NORGES BANK | 259K | $96.3M | — | 0.879% | 0.01% |
| 21 | Jupiter Topco LLC | 257K | $95.4M | — | 0.871% | 0.04% |
| 22 | BANK OF AMERICA CORP /DE/ | 256K | $95.3M | -1.6% | 0.870% | 0.01% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 255K | $94.7M | +5.3% | 0.864% | 0.01% |
| 24 | MORGAN STANLEY | 235K | $87.5M | +12.6% | 0.799% | 0.00% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 190K | $70.4M | +5.8% | 0.643% | 0.02% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KRYS — a direct measure of their conviction.
| 95.30% |
| 2.27 pp |
| $4.71B |
| +12% |
| Q4 2024 | 259 | 5.8% | 97.57% | 1.82 pp | $4.19B | 15% |
| Q3 2024 | 275 | — | 99.39% | — | $4.95B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
85 institutions opened new positions in KRYS during Q2 2026, while 34 fully exited. 299 added to existing positions and 29 trimmed.
KRYS institutional ownership rose by 6.11 percentage points quarter-over-quarter, with a net change of +57 holders.
The top 10 institutions account for 64.6% of all reported 13F value in KRYS, and the top 25 account for 82.2%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Krystal Biotech, Inc. (KRYS) Institutional Ownership